Advertisement

Topics

PharmaJet Releases Positive Phase I Results for Hantavirus Vaccines

20:00 EDT 13 Mar 2018 | BioSpace

PharmaJet released positive interim results from the U.S. Army’s Phase I clinical trial of two hantavirus vaccines to prevent hemorrhagic fever with renal syndrome (HFRS).

Original Article: PharmaJet Releases Positive Phase I Results for Hantavirus Vaccines

NEXT ARTICLE

More From BioPortfolio on "PharmaJet Releases Positive Phase I Results for Hantavirus Vaccines"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...